Screening for impaired visual acuity in older adults : systematic review for the U.S. Preventive Services Task Force

Screening for impaired visual acuity in older adults systematic review for the U.S. Preventive Services Task Force

BACKGROUND: Impaired visual acuity is common in older adults. In 2009, the U.S. Preventive Services Task Force (USPSTF) found insufficient evidence to assess the balance of benefits and harms of screening for visual acuity in older adults (I statement). PURPOSE: This review updates the prior USPSTF...

Full description

Bibliographic Details
Other Authors: Chou, Roger, author (author)
Format: eBook
Language:Inglés
Published: Rockville, MD : Agency for Healthcare Research and Quality 2022.
Series:AHRQ publication.
Subjects:
Vision disorders > Diagnosis.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820264906719
Table of Contents:
  • 1. Introduction
  • Purpose and Previous U.S. Preventive Services Task Force Recommendation
  • Condition Definition
  • Prevalence and Burden of Disease
  • Etiology and Natural History
  • Risk Factors
  • Rationale for Screening/Screening Strategies
  • Interventions/Treatment
  • Current Clinical Practice
  • Recommendations of Other Groups
  • 2. Methods
  • Key Questions and Analytic Framework
  • Search Strategies
  • Study Selection
  • Data Abstraction and Quality Rating
  • Data Synthesis
  • External Review
  • Response to Public Comments
  • 3. Results
  • Key Question 1 Does Vision Screening in Asymptomatic Older Adults Result in Improved Vision, Morbidity or Mortality, Quality of Life, Functional Status, or Cognition?
  • Key Question 2 Are There Harms Associated With Vision Screening in Asymptomatic Older Adults?
  • Key Question 3 What Is the Accuracy of Screening for Early Impairment in Visual Acuity Due to Uncorrected Refractive Error, Cataracts, or AMD?
  • Key Question 4 Does Treatment of Early Impairment in Visual Acuity Due to Uncorrected Refractive Error, Cataracts, or AMD Lead to Improved Morbidity or Mortality or Quality of Life?
  • Key Question 5 Are There Harms Associated With Treating Early Impairment in Visual Acuity Due to Uncorrected Refractive Error, Cataracts, or AMD?
  • Contextual Question What Is a Clinically Meaningful Difference in Visual Acuity?
  • 4. Discussion
  • Summary of Review Findings
  • Limitations
  • Emerging Issues/Next Steps
  • Relevance for Priority Populations
  • Future Research
  • Conclusions
  • References
  • Appendix A Detailed Methods
  • Appendix B Evidence Tables From Prior USPSTF Review
  • Appendix C Evidence and Quality Tables of Published Studies From This Update
  • Appendix D Appendix Figures.

Similar Items